{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"ceroid-lipofuscinosis-neuronal-6b-kufs-type","columns":[{"countQualifier":"Onset group unspecified","gene":"CLN6","key":"population-59408fd704e86c4159af","label":"CLN6, adult Kufs entry","mondoId":"MONDO:0008768","onsetQualifier":null,"originColumnKey":"MONDO:0008768","originalViews":[{"key":"MONDO:0008768","label":"CLN6, adult Kufs entry","scopeLabel":"Adult presentation","sourceScope":null}],"recordKeys":["173bc9e675f1ec7ca8ae6e53d77e9cf1658834564b492d7d2805fd6ecf7914f4","1a291aba15a141c62b766b4bf6519ab56bc9d390c6fc432ebc6fb79137fc38b7","240e365ffacae31c57bb6d65b29b0cf68a909c79fa900a6e961be4bdb2d0b755","2af3fe7b9e84479c2a875fa864c1b3b67234887b27df58631fdf02152a8d9271","3cf54a7c8956fcad18dad1ecf1105a7b0b68c1ab4c1ee399f38819867c97036e","41bd6db3accb68ec2ba70fe6be219b63fe9b76dc65f853c5dcaad67d6112c03e","607334b1f840a7ec3291595f7ca741b3ba1caaccbc4e51eeefd96ad36a7cdf80","66bde91e829c27098eb2d6aaf93b60f909261047ca174af1abace3a6e93c73e3","86a0e84b8005805ba46cae6f4d1851b390913b20e435802934bfcb049e511784","8b3ff5a811f0ac9993f4b52670bd7a6114fd344816b14f4557636a6728d6db04","a2f251f92105fc7cfdef6963ac9961d12e8459d279a9a98826041b09e35147b9","a44d5192aed24aead24722ef5f1e9bac03c001997393a197ea12ac628b541bab","b361efc418ec25e00361f5e4d0f2db3cc2e988f613feed906e0947e441798dce","b39bd2e4a521de057c3c409c5fe538e0320fb21b385b916b61b7e0c5172215c5","b9ccb92071c3cfd8e0dd55d1824e8dd18f77990ddc23c87aaab91a54336f8ebc","bb99ce467505341a69c2a92f5e42156726df0c96ecfc0b5e920e58faf9834e38","eb118e2205405914c46cef7becc6ef3e22354167bb3fd3e0aab51788b40a7cb6","ece7fdb9ccd7488fb512de9c6333c25be6642fa920c96cca6193553729fd365b"],"recordQualifiers":{"240e365ffacae31c57bb6d65b29b0cf68a909c79fa900a6e961be4bdb2d0b755":"Onset group unspecified","86a0e84b8005805ba46cae6f4d1851b390913b20e435802934bfcb049e511784":"Onset group unspecified","8b3ff5a811f0ac9993f4b52670bd7a6114fd344816b14f4557636a6728d6db04":"Onset group unspecified","a2f251f92105fc7cfdef6963ac9961d12e8459d279a9a98826041b09e35147b9":"Onset group unspecified","a44d5192aed24aead24722ef5f1e9bac03c001997393a197ea12ac628b541bab":"Onset group unspecified","b361efc418ec25e00361f5e4d0f2db3cc2e988f613feed906e0947e441798dce":"Onset group unspecified","b9ccb92071c3cfd8e0dd55d1824e8dd18f77990ddc23c87aaab91a54336f8ebc":"Onset group unspecified"},"scopeLabel":"Adult presentation","sourceIds":["OMIM:204300"],"sourceScope":null}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-59408fd704e86c4159af"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002071","HP:0001251","HP:0008765","HP:0002069","HP:0002059","HP:0003205","HP:0000726"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":18,"sourceGroups":{"omim":11,"published":7}},"features":[{"hpoId":"HP:0002071","label":"Abnormality of extrapyramidal motor function","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0008765","label":"Auditory hallucination","primary":true},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0003205","label":"Curvilinear intracellular accumulation of autofluorescent lipopigment storage material","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":true},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0003208","label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","primary":false},{"hpoId":"HP:0007359","label":"Focal-onset seizure","primary":false},{"hpoId":"HP:0002074","label":"Increased neuronal autofluorescent lipopigment","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0003226","label":"Rectilinear intracellular accumulation of autofluorescent lipopigment storage material","primary":false},{"hpoId":"HP:0031475","label":"Status epilepticus without prominent motor symptoms","primary":false},{"hpoId":"HP:0003657","label":"Vascular granular osmiophilic material deposition","primary":false},{"hpoId":"HP:0002367","label":"Visual hallucination","primary":false}],"ledeHtml":"","mondoId":"MONDO:0008768","node":{"canonicalSlug":"ceroid-lipofuscinosis-neuronal-6b-kufs-type","comparisons":[{"documentSha256":"feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069","key":"legacy-cln","kind":"legacy","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cln.feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069.json"},{"documentSha256":"df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3","key":"expanded-cln","kind":"expanded","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012188","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295","MONDO:0017809","MONDO:0019260","MONDO:0019261","MONDO:0019262","MONDO:0030947","MONDO:0850001"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-df7e5010cb40de30aba1.df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3.json"}],"contexts":[{"causes":["Mutations in the CLN6 gene cause CLN6 disease. The CLN6 gene provides instructions for making a protein whose function is not well understood. Within cells, the CLN6 protein is found in a structure called the endoplasmic reticulum, which is involved in protein processing and transport. Research suggests that the CLN6 protein helps cells get rid of materials they no longer need.","Most CLN6 gene mutations result in the production of an abnormal CLN6 protein that is quickly broken down (degraded). As a result, there is a severe reduction in the amount of functional CLN6 protein in cells. While it is not known how the loss of this protein causes the signs and symptoms of CLN6 disease, it is likely that the protein's quick degradation contributes to the childhood onset of CLN6 disease.","In the cases in which CLN6 disease develops in adulthood, CLN6 gene mutations often result in a CLN6 protein with reduced function. Research suggests that these CLN6 gene mutations allow enough functional protein to be produced so that signs and symptoms of the disorder do not develop until later in life.","CLN6 disease, like other NCLs, is characterized by the accumulation of proteins and other substances in lysosomes, which are cell structures that digest and recycle different types of molecules. These accumulations occur in cells throughout the body; however, nerve cells seem to be particularly vulnerable to their effects. The accumulations can cause cell damage leading to cell death. The progressive death of nerve cells in the brain and other tissues leads to the signs and symptoms of CLN6 disease. However, it is unclear how mutations in the CLN6 gene are involved in the buildup of substances in lysosomes in CLN6 disease. These accumulations occur in more cells throughout the body in children with CLN6 disease than in affected adults."],"causesUrl":"https://medlineplus.gov/genetics/condition/cln6-disease/#causes","contentForm":"summary","matchMethod":"reviewed-binding","name":"CLN6 disease","paragraphs":["CLN6 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition typically begin between early and late childhood, but sometimes they can appear in adulthood.","Most children with CLN6 disease initially experience the loss of previously acquired skills (developmental regression). Affected individuals can also develop recurrent seizures (epilepsy), difficulty coordinating movements (ataxia), muscle twitches (myoclonus), impaired speech (dysarthria), and vision loss. The movement problems worsen over time until affected children cannot walk, stand, or sit without assistance. Intellectual function also declines over time. Most children with CLN6 disease do not survive into adulthood.","Some people with CLN6 disease do not show signs or symptoms of the condition until adulthood, typically after age 30. These individuals can have epilepsy, ataxia, dysarthria, and a progressive loss of intellectual function. CLN6 disease usually does not cause vision loss in affected adults. Adults with this condition do not often survive more than 10 years after diagnosis.","CLN6 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), which may also be collectively referred to as Batten disease. All these disorders affect the nervous system and typically cause worsening problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation \"CLN,\" meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype."],"reviewed":"2017-01","scope":"broader","scopeNote":"The CLN6 article covers childhood and adult-onset disease, not only the adult Kufs presentation. This node’s feature table retains its adult source populations.","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/cln6-disease"}],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-59408fd704e86c4159af"],"publication":"published","relationships":[{"kind":"parent","label":"neuronal ceroid lipofuscinosis","mondoId":"MONDO:0016295","slug":"cln"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/6845"}],"translation":"published"},"records":[{"frequencyKind":"reported","key":"173bc9e675f1ec7ca8ae6e53d77e9cf1658834564b492d7d2805fd6ecf7914f4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008765","is_excluded":false,"label":"Auditory hallucination","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1a291aba15a141c62b766b4bf6519ab56bc9d390c6fc432ebc6fb79137fc38b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"240e365ffacae31c57bb6d65b29b0cf68a909c79fa900a6e961be4bdb2d0b755","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"2/14","hpo_id":"HP:0007359","is_excluded":false,"label":"Focal-onset seizure","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2af3fe7b9e84479c2a875fa864c1b3b67234887b27df58631fdf02152a8d9271","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003657","is_excluded":false,"label":"Vascular granular osmiophilic material deposition","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3cf54a7c8956fcad18dad1ecf1105a7b0b68c1ab4c1ee399f38819867c97036e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002367","is_excluded":false,"label":"Visual hallucination","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"41bd6db3accb68ec2ba70fe6be219b63fe9b76dc65f853c5dcaad67d6112c03e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003208","is_excluded":false,"label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"607334b1f840a7ec3291595f7ca741b3ba1caaccbc4e51eeefd96ad36a7cdf80","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"66bde91e829c27098eb2d6aaf93b60f909261047ca174af1abace3a6e93c73e3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003226","is_excluded":false,"label":"Rectilinear intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"86a0e84b8005805ba46cae6f4d1851b390913b20e435802934bfcb049e511784","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"9/14","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8b3ff5a811f0ac9993f4b52670bd7a6114fd344816b14f4557636a6728d6db04","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a2f251f92105fc7cfdef6963ac9961d12e8459d279a9a98826041b09e35147b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"8/14","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a44d5192aed24aead24722ef5f1e9bac03c001997393a197ea12ac628b541bab","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"7/11","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b361efc418ec25e00361f5e4d0f2db3cc2e988f613feed906e0947e441798dce","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"1/14","hpo_id":"HP:0031475","is_excluded":false,"label":"Status epilepticus without prominent motor symptoms","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b39bd2e4a521de057c3c409c5fe538e0320fb21b385b916b61b7e0c5172215c5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003205","is_excluded":false,"label":"Curvilinear intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b9ccb92071c3cfd8e0dd55d1824e8dd18f77990ddc23c87aaab91a54336f8ebc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"PCS","frequency_raw":"8/14","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"PMID:21549341","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bb99ce467505341a69c2a92f5e42156726df0c96ecfc0b5e920e58faf9834e38","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"eb118e2205405914c46cef7becc6ef3e22354167bb3fd3e0aab51788b40a7cb6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002074","is_excluded":false,"label":"Increased neuronal autofluorescent lipopigment","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ece7fdb9ccd7488fb512de9c6333c25be6642fa920c96cca6193553729fd365b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:204300","disease_name":"Ceroid lipofuscinosis, neuronal, 6B (Kufs type)","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"OMIM:204300","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln6-disease\" rel=\"noreferrer\">MedlinePlus</a> · The CLN6 article covers childhood and adult-onset disease, not only the adult Kufs presentation. This node’s feature table retains its adult source populations.</p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>This source describes a broader group, rather than this exact condition.</p><p>CLN6 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition typically begin between early and late childhood, but sometimes they can appear in adulthood.</p><p>Most children with CLN6 disease initially experience the loss of previously acquired skills (developmental regression). Affected individuals can also develop recurrent seizures (epilepsy), difficulty coordinating movements (ataxia), muscle twitches (myoclonus), impaired speech (dysarthria), and vision loss. The movement problems worsen over time until affected children cannot walk, stand, or sit without assistance. Intellectual function also declines over time. Most children with CLN6 disease do not survive into adulthood.</p><p>Some people with CLN6 disease do not show signs or symptoms of the condition until adulthood, typically after age 30. These individuals can have epilepsy, ataxia, dysarthria, and a progressive loss of intellectual function. CLN6 disease usually does not cause vision loss in affected adults. Adults with this condition do not often survive more than 10 years after diagnosis.</p><p>CLN6 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), which may also be collectively referred to as Batten disease. All these disorders affect the nervous system and typically cause worsening problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation &quot;CLN,&quot; meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln6-disease\" rel=\"noreferrer\">MedlinePlus</a> · The CLN6 article covers childhood and adult-onset disease, not only the adult Kufs presentation. This node’s feature table retains its adult source populations.</p>","key":"context-0","title":"Broader context: CLN6 disease"}],"sharedSources":[],"slug":"ceroid-lipofuscinosis-neuronal-6b-kufs-type","sourceDocuments":[{"name":"MedlinePlus: CLN6 disease","reviewed":"2017-01","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/cln6-disease"}],"sourceNote":"","synonyms":["adult neuronal ceroid lipofuscinosis 4A","ceroid lipofuscinosis, neuronal, 4A, autosomal recessive","CLN4A","CLN6 neuronal ceroid lipofuscinosis","Kuf's disease type A","Kuf's disease, autosomal recessive","neuronal ceroid lipofuscinosis caused by mutation in CLN6","neuronal ceroid lipofuscinosis type 4A"],"takeawayHtml":"","title":"ceroid lipofuscinosis, neuronal, 6B (Kufs type)"},"schemaVersion":1}
